secwatch.observer — SEC 8-K summary
======================================

Issuer:     PepGen Inc. (PEPG)
CIK:        0001835597
Form:       8-K
Filed at:   2024-02-07T23:59:59+00:00
Accession:  0001193125-24-025921
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PepGen prices $80.1M common stock offering of 7.53M shares at $10.635 per share
-------------------------------------------------------------------------------

- Gross proceeds ~$80.1M; net proceeds ~$76.4M after underwriting discounts and expenses.
- Offering led by RA Capital Management; 11 institutional investors including Adage, Frazier, Janus.
- Net proceeds to fund R&D and clinical development of oligonucleotide therapies; cash runway into 2026.
- Offering expected to close February 9, 2024; Leerink Partners sole bookrunner.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835597/000119312524025921/0001193125-24-025921-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835597/000119312524025921/d695469d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-025921

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer